2020
DOI: 10.1111/jdv.16422
|View full text |Cite
|
Sign up to set email alerts
|

Drp1 expression levels correlate with clinical stage in extramammary Paget’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 10 publications
(19 reference statements)
0
8
0
Order By: Relevance
“…A 'magic bullet' type of drug is unlikely to evolve soon, as the pathogenesis of AD is quite complex. 4 The first biologic is licensed for AD, 5 and additional innovative drugs will be approved soon. As these therapies will possess unprecedented efficacy, treatment goals in AD must be defined.…”
Section: European Task Force On Atopic Dermatitis (Etfad): Treatment mentioning
confidence: 99%
See 2 more Smart Citations
“…A 'magic bullet' type of drug is unlikely to evolve soon, as the pathogenesis of AD is quite complex. 4 The first biologic is licensed for AD, 5 and additional innovative drugs will be approved soon. As these therapies will possess unprecedented efficacy, treatment goals in AD must be defined.…”
Section: European Task Force On Atopic Dermatitis (Etfad): Treatment mentioning
confidence: 99%
“…As observed by Fougerosse et al, 1 PASI-90 results were lower than that observed in phase III studies Voyage 1 (73.3%) and Voyage 2 (70%). 4,5 We compared the effectiveness of guselkumab at week 16 by assessing the number of patients who achieved PASI-100, PASI-90 and PASI-75 according to severity of the PASI at baseline and according to their belonging to the bio-naive or bio-experienced group. Effectiveness at week 16 is summarized in Table 1.…”
Section: Dear Editormentioning
confidence: 99%
See 1 more Smart Citation
“…18 Immunostaining was evaluated by the same observer; the total immunostaining score for CDK4 and cyclin D1 was calculated as the sum of proportion scores (0, absent; 1, 0%-25%; 2, 25%-50%; 3, 50%-75%; and 4, 75%-100%) and intensity scores (0, absent; 1, faint; 2, moderate; and 3, strong) in accordance with our previous study. 19 The proportion of immunoreactive cells was determined by counting 100 cells in three randomly chosen fields.…”
Section: Histopathologicalanalysesmentioning
confidence: 99%
“…To analyse the protein expressions of RANK/RANKL in CAS, we performed immunohistochemical analysis using samples of CAS and pyogenic granuloma (PG) ( n = 12, 8, respectively). Immunostaining score (IS) was evaluated according to the previous study 5 . The expression levels of RANK in CAS and PG were higher than those in normal endothelial cells ( P < 0.001) (Fig.…”
Section: Figurementioning
confidence: 99%